SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044034
Filing Date
2021-08-12
Accepted
2021-08-12 16:56:14
Documents
78
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acor-10q_20210630.htm   iXBRL 10-Q 2209577
2 EX-31.1 acor-ex311_9.htm EX-31.1 16406
3 EX-31.2 acor-ex312_11.htm EX-31.2 15948
4 EX-32.1 acor-ex321_10.htm EX-32.1 6660
5 EX-32.2 acor-ex322_12.htm EX-32.2 7103
  Complete submission text file 0001564590-21-044034.txt   9368486

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acor-20210630.xsd EX-101.SCH 58740
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acor-20210630_cal.xml EX-101.CAL 62601
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acor-20210630_def.xml EX-101.DEF 198836
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210630_lab.xml EX-101.LAB 494751
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210630_pre.xml EX-101.PRE 374534
11 EXTRACTED XBRL INSTANCE DOCUMENT acor-10q_20210630_htm.xml XML 1950806
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31938 | Film No.: 211168425
SIC: 2836 Biological Products, (No Diagnostic Substances)